Boulder, CO, United States of America

Eric Lodewijk

This inventor holds 3 USPTO granted patents. Top assignee: Syntex (u.s.a.) Inc.. Active years: 1990-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric Lodewijk. Retrieved from https://idiyas.com/inventor/eric-lodewijk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1990-1997

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Eric Lodewijk

Introduction

Eric Lodewijk is a notable inventor based in Boulder, CO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. With a total of 3 patents to his name, Lodewijk's work has had a meaningful impact on medical science.

Latest Patents

Among his latest patents is the resolution of ibuprofen, where (S)-ibuprofen can be separated from a mixture of (S)-ibuprofen and (R)-ibuprofen in high yield and enantiomeric purity using an N-alkyl-D-glucamine as the resolving agent. Another significant patent involves the preparation of N-9 substituted guanine compounds, which relates to efficient and selective processes for synthesizing the antiviral compounds acyclovir and ganciclovir.

Career Highlights

Lodewijk is currently employed at Syntex (U.S.A.) Inc., where he continues to innovate and contribute to the pharmaceutical industry. His work has been instrumental in advancing the development of effective antiviral medications.

Collaborations

He has collaborated with notable coworkers such as George C. Schloemer and Yeun-Kwei Han, further enhancing the scope and impact of his research.

Conclusion

Eric Lodewijk's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in antiviral treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…